Related Experiment Video
Updated: May 17, 2026
07:45
An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
Published on: October 21, 2014
Neonatal adrenoleukodystrophy: a clinical, pathologic, and biochemical study.
1Neurology Department at School of Medicine, University of Washington, Seattle, Washington, USA. donf@u.washington.edu
Pediatric Neurology
|October 10, 2012
Summary
Neonatal adrenoleukodystrophy is a genetic disorder characterized by severe infant symptoms and distinct lipid storage. Its unique brain lipid profile, particularly elevated vinyl ether plasmalogens, differentiates it from Zellweger syndrome.
Area of Science:
- Biochemistry
- Genetics
- Neonatal Medicine
Background:
- Neonatal adrenoleukodystrophy (NALD) is an autosomal recessive genetic disorder.
- NALD shares very long chain fatty acid (VLCFA) storage with Zellweger syndrome and X-linked adrenoleukodystrophy but is clinically and biochemically distinct.
- Clinical features of NALD include hypotonia, psychomotor retardation, failure to thrive, blindness, deafness, and seizures, often present at birth.
Observation:
- Infants with NALD exhibit a characteristic retinopathic "leopard spot" pattern.
- Biochemical analysis of brains from NALD infants revealed abnormal complex lipid profiles.
- Specific analyses focused on very long chain fatty acids (VLCFAs) and brain plasmalogens.
Findings:
- NALD brains showed accumulation of VLCFAs, particularly in cholesterol esters.
- Marked elevation of vinyl ether ethanolamine plasmalogens was identified in NALD brains.
- The presence of stored vinyl ether plasmalogens distinguishes NALD from Zellweger syndrome, which cannot synthesize plasmalogens.
Implications:
- The distinct lipid storage pattern, especially elevated vinyl ether plasmalogens, serves as a key diagnostic marker for NALD.
- Understanding these biochemical differences aids in differentiating NALD from other leukodystrophies.
- This research contributes to the understanding of lipid metabolism disorders in neonates.
More Related Videos
Related Concept Videos
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:21Smooth Endoplasmic Reticulum
Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...